|
SLC31A1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.94780000000372E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.215700E-04 |
| Normal-vs-Stage2 |
5.893000E-01 |
| Normal-vs-Stage3 |
4.75659999998879E-06 |
| Normal-vs-Stage4 |
3.54939999946957E-07 |
| Stage1-vs-Stage2 |
4.232100E-02 |
| Stage1-vs-Stage3 |
5.953900E-02 |
| Stage1-vs-Stage4 |
1.467670E-02 |
| Stage2-vs-Stage3 |
4.719600E-03 |
| Stage2-vs-Stage4 |
6.367900E-04 |
| Stage3-vs-Stage4 |
2.405200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.05659999999996E-05 |
| Normal-vs-AfricanAmerican |
2.784900E-03 |
| Normal-vs-Asian |
1.392640E-04 |
| Caucasian-vs-AfricanAmerican |
8.766400E-01 |
| Caucasian-vs-Asian |
4.906800E-01 |
| AfricanAmerican-vs-Asian |
7.149000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.242180E-03 |
| Normal-vs-Female |
3.98320000000174E-05 |
| Male-vs-Female |
7.911600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.939090E-03 |
| Normal-vs-Age(41-60Yrs) |
2.03460000000044E-05 |
| Normal-vs-Age(61-80Yrs) |
1.776000E-03 |
| Normal-vs-Age(81-100Yrs) |
3.982800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.236810E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.629400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.649000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.893200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.595200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.678400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.737000E-03 |
| Classical-VS-Follicular |
1.266130E-02 |
| Classical-VS-Other |
1.201400E-01 |
| Classical-VS-Normal |
3.85539999999684E-05 |
| Tall-VS-Follicular |
4.07310000000161E-05 |
| Tall-VS-Other |
6.990600E-01 |
| Tall-VS-Normal |
1.23870000034998E-07 |
| Follicular-VS-Other |
4.613900E-02 |
| Follicular-VS-Normal |
3.109200E-01 |
| Other-VS-Normal |
7.001500E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.917600E-03 |
| Normal-vs-N1 |
8.94730001199662E-09 |
| N0-vs-N1 |
9.82520000000209E-05 |
|
|
